Translate
Violation Detail
Standard Cited: 19100134 C01 Respiratory Protection.
Inspection Nr: 1758228.015
Citation: 01001A
Citation Type: Serious
Abatement Status: Corrected During Inspection
Initial Penalty: $11,524.00
Current Penalty: $11,524.00
Issuance Date: 12/23/2024
Nr Instances: 1
Nr Exposed: 15
Abatement Date:
Gravity: 5
Report ID: 0213400
Contest Date: 01/21/2025
Final Order:
Related Event Code (REC): C
Emphasis:
Substance: 1470
| Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
|---|---|---|---|---|---|---|
| Penalty | C: Contested | 01/24/2025 | $11,524.00 | Serious | ||
| Penalty | Z: Issued | 12/23/2024 | $11,524.00 | Serious |
Text For Citation: 01 Item/Group: 001A Hazard:
29 CFR 1910.134(c)(1): A written respiratory protection program that included the provisions in 29 CFR 1910.134(c)(1)(i) - (ix) with worksite specific procedures was not established and implemented for required respirator use: (a) QuVa Pharma, Inc 519 State Route 173 Bloomsbury, NJ 08804 prep room in Building 1 and 2 On or about June 27, 2024, and thereafter, employee(s) were provided and required to use Alpha ProTech N-95 Particulate Respirator during the wiping process of medical equipment such as Syringes and IV bags using STERI-PEROX wipes containing 6% hydrogen peroxide as part of their daily duties, for which the employer did not have a written program for administering the use of respiratory protection in the workplace. Employee(s) were exposed to health hazard(s), including inhalation of toxic/hazardous substances such as hydrogen peroxide, as well as cardio-respiratory impacts from using a tight-fitting, negative-pressure respirator.